- On-Demand
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
- Available: June 8, 2021 —
- June 7, 2022
- Credit: 0.50hr(s)
- Credit Types: CME
- Therapeutic Areas: Neurology
- Specialties: Amyotrophic Lateral Sclerosis
- Location: Internet Activity Enduring
Course Description
In this activity, an expert in neurology discusses the use of antisense oligonucleotide therapies in patients with amyotrophic lateral sclerosis (ALS).